Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Glyburide measurement |
Component |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Poisoning by glibenclamide |
Causative agent (attribute) |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Accidental poisoning by glibenclamide |
Causative agent (attribute) |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
2 |
Intentional poisoning by glibenclamide |
Causative agent (attribute) |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
2 |
Poisoning caused by glibenclamide of undetermined intent |
Causative agent (attribute) |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide adverse reaction |
Causative agent (attribute) |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Allergy to glibenclamide (finding) |
Causative agent (attribute) |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
|
Overdose of glibenclamide |
Causative agent (attribute) |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Accidental overdose by glibenclamide |
Causative agent (attribute) |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Intentional overdose by glibenclamide |
Causative agent (attribute) |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
surdose de glibenclamide d'intention indéterminée |
Causative agent (attribute) |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
|
Glibenclamide 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
|
Glibenclamide 1.25 mg and metformin hydrochloride 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
|
Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
|
Glibenclamide 5 mg and metformin hydrochloride 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
|
Product containing glibenclamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide micronised 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
|
Glibenclamide micronised 4.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
|
Glibenclamide 6.3 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
|
Product containing precisely glibenclamide micronized 6 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
|
Glibenclamide micronised 3 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
|
Glibenclamide 1.25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
|
Product containing glibenclamide and metformin hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
|
Glibenclamide micronised |
Is a |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
|
Allergy to glibenclamide (finding) |
Causative agent (attribute) |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 1.25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 1.25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 6.3 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 6.3 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 1.25 mg and metformin hydrochloride 250 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 5 mg and metformin hydrochloride 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
2 |
Glibenclamide 5 mg and metformin hydrochloride 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
2 |
Glibenclamide 5 mg and metformin hydrochloride 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 1.25 mg and metformin hydrochloride 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
2 |
Glibenclamide 1.25 mg and metformin hydrochloride 250 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
2 |
Glibenclamide micronised |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
|
Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
2 |
Glibenclamide 5 mg and metformin hydrochloride 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 1.25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 6.3 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 1.25 mg and metformin hydrochloride 250 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Product containing glibenclamide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Product containing glibenclamide and metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
2 |
Product containing glibenclamide and metformin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
2 |
Glibenclamide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Product containing only glibenclamide and metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
2 |
Product containing only glibenclamide and metformin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
2 |
Product containing only glibenclamide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 1.25 mg and metformin hydrochloride 250 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
2 |
Glibenclamide 5 mg and metformin hydrochloride 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
2 |
Glibenclamide 3.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 3.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 1.75 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |
Glibenclamide 1.75 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glibenclamide (substance) |
Inferred relationship |
Some |
1 |